Drugs for direct patient care

Ended Awarded Last action

Contract number
36C25819N0230
Awardee
Awarding agency
Obligated
$920,784

Award facts

Opportunity
Contract value 100% obligated
$920,784.38 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
King of Prussia, PA 19406, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 -$32
Supplemental Agreement for work within scope P00003 -$14,336
Supplemental Agreement for work within scope P00001 $13,932
Original award $921,220

About this award

This contract award is for the delivery of pharmaceutical drugs to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The prime contractor is CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The contract has a potential value of $920,784.38 and is a firm fixed price delivery order against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with the General Services Administration (GSA). The contract is to provide specialty pharmaceuticals such as the Hereditary Angioedema treatment HAEGARDA and the intravenous immunoglobulin Privigen to VA medical centers and support healthcare programs for veterans. The contract has no set-aside designation and the place of performance is at CSL Behring's facility in King of Prussia, Pennsylvania.

Quick answers

Who was awarded contract 36C25819N0230?

36C25819N0230 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 22 (Veterans Health Administration) on April 4, 2019.

How much is contract 36C25819N0230 worth?

The government has obligated $920,784 on 36C25819N0230.

Is contract 36C25819N0230 an order under another contract?

Yes. 36C25819N0230 is a delivery order under V797D50358, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25819N0230 competed?

The extent of competition for 36C25819N0230 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award